FERREX 28 - ascorbic acid, folic acid, cyanocobalamin, iron, ferrous fumurate and succinic acid   
Breckenridge Pharmaceutical, Inc.

----------

Ferrex™ 28
ONCE-DAILY

Rx Only

DESCRIPTION

Ferrex™ 28 Tablets for oral administration to provide 28-day iron supplement therapy.

Each maroon film-coated tablet contains:
Vitamin C (Ascorbic Acid) .................................... 140 mg
Vitamin C
  Ascorbic Acid (as Calcium Ascorbate)................... 60 mg
  Threonic Acid (as Calcium Threonate) .................. 0.8 mg
Folic Acid, USP ........................................................ 1 mg
Vitamin B12 (Cyanocobalamin) ................................10 mcg
Iron (as Ferrous Asparto Glycinate) .......................... 70 mg
Iron (as Ferrous Fumarate)........................................ 81 mg
Succinic Acid.......................................................... 150 mg

Inactive Ingredients: Citric Acid, Croscarmellose Sodium, Crospovidone, Dicalcium Phosphate, FD&C Blue No. 1 Lake, FD&C Red No. 40 Lake, FD&C Yellow No. 6 Lake1, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Pharmaceutical Glaze, Polyethylene Glycol, Polyvinylpyrrolidone, Silica, Sodium Lauryl Sulfate, Soy Polysaccharide, Stearic Acid and Titanium Dioxide.

Allergen: Contains Soy.

Each blue film-coated tablet contains:
Succinic Acid..................................................... 150 mg

Inactive Ingredients: Croscarmellose Sodium, Crospovidone, Dicalcium Phosphate, FD&C Blue No. 1 Lake, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Silica, Soy Polysaccharide, Stearic Acid, Titanium Dioxide and Triacetin.

Allergen: Contains Soy.


1
This product contains FD&C Yellow No. 6 Lake as a color additive.

INDICATIONS AND USAGE

For the nutritional supplementation of anemias responsive to oral iron, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence.

CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindications to iron supplementation.

WARNINGS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

WARNING

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

General

Do not exceed recommended dose.

The type of anemia and the underlying cause or causes should be determined before taking Ferrex™ 28 Tablets. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.

Folic Acid

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use

Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug supplementation.

If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or health-care provider before using or continuing use.

ADVERSE REACTIONS

Adverse reactions with iron supplementation may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron supplementation are usually transient.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

OVERDOSAGE

The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

DOSAGE AND ADMINISTRATION

Usual adult dose is 1 tablet daily, or as directed by a physician. Ferrex™ 28 supplies a 28 day course of iron supplementation that consists of 21 maroon active tablets and 7 blue absorption period tablets. Take 1 maroon tablet daily for 21 days, followed by 1 blue tablet daily for 7 days. After 28 tablets have been taken, a new course may be started if prescribed.

HOW SUPPLIED

Ferrex™ 28 Tablets are available as 21 maroon active tablets debossed "B 586" and 7 blue absorption period tablets debossed "B 587". Supplied in packages of 28 tablets each containing 4 child-resistant blisters of 7 tablets. NDC 51991-588-28.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.

Storage and Handling

Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). See USP Controlled Room Temperature.

Protect from light and moisture.

Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP/NF.

All prescription substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Rx Only

Manufactured by:
Contract Pharmacal Corp.
Hauppauge, NY 11788 USA

Distributed by:
Breckenridge Pharmaceutical, Inc.
Boca Raton, FL 33487

Iss. 05/09

PRINCIPAL DISPLAY PANEL - Carton

Breckenridge
Pharmaceutical, Inc.

NDC 51991-588-28

Ferrex™ 28
ONCE-DAILY

Rx Only

28 Tablets
(21 active, 7 absorption period tablets)

PRINCIPAL DISPLAY PANEL - Carton

FERREX 28 
ascorbic acid, folic acid, cyanocobalamin, iron, ferrous fumurate and succinic acid   kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 51991-588
Packaging
# NDC Package Description Multilevel Packaging
1 51991-588-28 1 KIT In 1 BLISTER PACK None
QUANTITY OF PARTS
Part # Package Quantity Total Product Quantity
Part 1   21 
Part 2  
Part 1 of 2
FERREX 28 
ascorbic acid, folic acid, cyanocobalamin, iron, ferrous fumurate and succinic acid   tablet, coated
Product Information
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Ascorbic Acid (Ascorbic Acid) Ascorbic Acid 200.8 mg
Folic Acid (Folic Acid) Folic Acid 1 mg
Cyanocobalamin (Cyanocobalamin) Cyanocobalamin 10 ug
Iron (Iron) Iron 70 mg
Ferrous Fumarate (Iron) Ferrous Fumarate 81 mg
Succinic Acid (Succinic Acid) Succinic Acid 150 mg
Inactive Ingredients
Ingredient Name Strength
Citric Acid Monohydrate  
Croscarmellose Sodium  
Crospovidone  
FD&C Blue No. 1  
FD&C Red No. 40  
Aluminum Oxide  
FD&C Yellow No. 6  
Hypromellose  
Magnesium Stearate  
Cellulose, Microcrystalline  
Mineral Oil  
Polyethylene Glycol  
Silicon Dioxide  
Sodium Lauryl Sulfate  
Stearic Acid  
Titanium Dioxide  
Product Characteristics
Color RED Score 2 pieces
Shape OVAL Size 7mm
Flavor Imprint Code B;586
Contains     
Packaging
# NDC Package Description Multilevel Packaging
Package Information Not Applicable
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved other 06/26/2009

Part 2 of 2
SUCCINIC ACID 
succinic acid   tablet, coated
Product Information
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Succinic Acid (Succinic Acid) Succinic Acid 150 mg
Inactive Ingredients
Ingredient Name Strength
Croscarmellose Sodium  
Crospovidone  
FD&C Blue No. 1  
Aluminum Oxide  
Hypromellose  
Magnesium Stearate  
Cellulose, Microcrystalline  
Mineral Oil  
Silicon Dioxide  
Stearic Acid  
Titanium Dioxide  
Triacetin  
Product Characteristics
Color BLUE Score 2 pieces
Shape OVAL Size 7mm
Flavor Imprint Code B;587
Contains     
Packaging
# NDC Package Description Multilevel Packaging
Package Information Not Applicable
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved other 06/26/2009


Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved other 06/26/2009

Labeler - Breckenridge Pharmaceutical, Inc. (150554335)
Establishment
Name Address ID/FEI Operations
Contract Pharmacal Corporation 057795122 MANUFACTURE
Revised: 07/2009 Breckenridge Pharmaceutical, Inc.